BNP Paribas Financial Markets’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-85
| Closed | -$296 | – | 5011 |
|
|
2022
Q3 | $296 | Buy |
+85
| New | +$325 | ﹤0.01% | 4575 |
|
|
2020
Q3 | – | Sell |
-165
| Closed | -$15.7K | – | 4328 |
|
|
2020
Q2 | $15.7K | Sell |
165
-470
| -74% | -$35K | ﹤0.01% | 3503 |
|
|
2020
Q1 | $32.6K | Buy |
635
+189
| +42% | +$19.8K | ﹤0.01% | 3747 |
|
|
2019
Q4 | $36.6K | Buy |
446
+146
| +49% | +$10.2K | ﹤0.01% | 3803 |
|
|
2019
Q3 | $25.7K | Buy |
300
+1
| +0.3% | +$107 | ﹤0.01% | 3839 |
|
|
2019
Q2 | $38.1K | Sell |
299
-93
| -24% | -$13.4K | ﹤0.01% | 3596 |
|
|
2019
Q1 | $70.7K | Buy |
392
+342
| +684% | +$49.5K | ﹤0.01% | 3323 |
|
|
2018
Q4 | $5.54K | Sell |
50
-16
| -24% | -$2.08K | ﹤0.01% | 3550 |
|
|
2018
Q3 | $8.93K | Sell |
66
-35
| -35% | -$4.83K | ﹤0.01% | 3788 |
|
|
2018
Q2 | $13.9K | Sell |
101
-287
| -74% | -$39.5K | ﹤0.01% | 3645 |
|
|
2018
Q1 | $53.5K | Sell |
388
-2
| -0.5% | -$272 | ﹤0.01% | 3525 |
|
|
2017
Q4 | $48K | Buy |
390
+186
| +91% | +$25.5K | ﹤0.01% | 3683 |
|
|
2017
Q3 | $27.9K | Sell |
204
-15
| -7% | -$2.26K | ﹤0.01% | 3433 |
|
|
2017
Q2 | $38.5K | Buy |
219
+203
| +1,269% | +$28.9K | ﹤0.01% | 3323 |
|
|
2017
Q1 | $1.88K | Sell |
16
-86
| -84% | -$8.95K | ﹤0.01% | 3552 |
|
|
2016
Q4 | $9.9K | Sell |
102
-28
| -22% | -$2.57K | ﹤0.01% | 3463 |
|
|
2016
Q3 | $12.2K | Buy |
130
+55
| +73% | +$5.51K | ﹤0.01% | 3116 |
|
|
2016
Q2 | $8.06K | Buy |
75
+62
| +477% | +$7.26K | ﹤0.01% | 3024 |
|
|
2016
Q1 | $1.56K | Sell |
13
-352
| -96% | -$37K | ﹤0.01% | 2451 |
|
|
2015
Q4 | $43.5K | Sell |
365
-39
| -10% | -$5.03K | ﹤0.01% | 2907 |
|
|
2015
Q3 | $68.9K | Buy |
404
+245
| +154% | +$47K | ﹤0.01% | 2636 |
|
|
2015
Q2 | $30.8K | Buy |
159
+114
| +253% | +$21.2K | ﹤0.01% | 2778 |
|
|
2015
Q1 | $6.64K | Buy |
+45
| New | +$6.85K | ﹤0.01% | 2991 |
|
|
2014
Q4 | – | Sell |
-111
| Closed | -$15.9K | – | 3452 |
|
|
2014
Q3 | $15.9K | Buy |
111
+100
| +909% | +$14.5K | ﹤0.01% | 3327 |
|
|
2014
Q2 | $1.48K | Sell |
11
-204
| -95% | -$25.9K | ﹤0.01% | 3269 |
|
|
2014
Q1 | $27.7K | Buy |
215
+191
| +796% | +$20.7K | ﹤0.01% | 2203 |
|
|
2013
Q4 | $2.58K | Sell |
24
-486
| -95% | -$47.2K | ﹤0.01% | 3526 |
|
|
2013
Q3 | $57.3K | Sell |
510
-150
| -23% | -$17K | ﹤0.01% | 2495 |
|
|
2013
Q2 | $74.4K | Buy |
+660
| New | +$80.7K | ﹤0.01% | 2596 |
|
Other funds holding SRGA
AC
AWS
BNP Paribas Financial Markets's SRGA Position: Q4 2022 in Review
BNP Paribas Financial Markets sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q4 2022, closing a stake of 85 shares — an estimated $296 sold.
BNP Paribas Financial Markets first reported a position in SRGA in Q2 2013 and held it in 29 quarters. The position peaked at $74.4K in Q2 2013. 35 funds tracked by Wall St. Rank hold SRGA as of Q4 2022.
- BNP Paribas Financial Markets reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
- BNP Paribas Financial Markets sold 85 Surgalign Holdings, Inc. Common Stock shares in Q4 2022, an estimated $296.
- BNP Paribas Financial Markets first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 29 quarters.
- BNP Paribas Financial Markets's Surgalign Holdings, Inc. Common Stock position peaked at $74.4K in Q2 2013.
- 35 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q4 2022.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2022, filed 14 Feb 2023.